TrialTransplantation2024

Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study.

Jun Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.